Table 2.
Treatment | Inclusion criteria | Exacerbation definition | |
---|---|---|---|
Mahler et al 2002 | Salmeterol/fluticasone versus fluticasone propionate, salmeterol or placebo | FEV1/FVC ≤ 70%
FEV1<65% predicted normal and >0.70L |
Exacerbation was defined by treatment and resulted in withdrawal from the study |
Hanania et al 2003 | Salmeterol/fluticasone versus fluticasone propionate, salmeterol or placebo | FEV1/FVC ≤ 70%
FEV1<65% predicted normal and >0.70L |
Moderate exacerbation: requiring treatment with. antibiotics and/or corticosteroids |
Severe exacerbation: requiring hospitalization | |||
Discontinuation after 1 exacerbation with inhaled or oral corticosteroids or hospitalization or 3 exacerbations treated with antibiotics | |||
TRISTAN Calverley et al 2003a | Salmeterol/fluticasone versus fluticasone propionate, salmeterol or placebo | FEV1/FVC ≤ 70%
FEV1 25%–70% predicted normal |
Exacerbation: a worsening of COPD symptoms that required treatment with antibiotics, oral corticosteroids or both. Episodes that required corticosteroids treatment of hospital admission were noted separately. |
Reversibility after 400 μg salbutamol: <10% of predicted normal. | |||
At least one exacerbation per year in the last three years. | |||
At least one exacerbation in the year immediately before the trial entry requiring treatment with oral corticosteroids, antibiotics or both. | |||
Dal Negro et al 2003 | Salmeterol/fluticasone versus salmeterol or placebo | FEV1/FVC ≤ 70%
FEV1 ≤ 80% predicted normal and >0,80L |
Mild exacerbation: condition requiring salbutamol prn >2 occasions/24 h period on 2 or more consecutive days compared with the baseline mean of last 7 days of run-in; |
Reversibility after 400 μg salbutamol: ≤ 12% as a percent of predicted normal
Regular treatment with 200 mg theophylline bid |
Moderate exacerbations: condition requiring treatment with antibiotics and/or oral corticosteroids;
Severe exacerbations: condition requiring emergency hospital treatment and/or hospitalization. |
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity